.

https://t.me/AnonymousX5
Server : Apache
System : Linux ls31.server.ly 3.10.0-962.3.2.lve1.5.68.el7.x86_64 #1 SMP Wed Apr 6 11:12:23 UTC 2022 x86_64
User : medchoco ( 2906)
PHP Version : 8.3.16
Disable Function : mail
Directory : /home/medchoco/mail/.z-elwerfalli@medcho_com/
Upload File :
Current File : /home/medchoco/mail/.z-elwerfalli@medcho_com/dovecot.index.cache
�Y[d�Y[dA�H����4	AMessage-Id: <1683708297.YgDRhTyE4H0b2Nn5@ls31.server.ly>
�Subject: =?UTF-8?B?W21lZGNoby5jb21dIENsaWVudCBjb25maWd1cmF0aW9uIHNldHRp?= =?UTF-8?B?bmdzIGZvciDigJx6LWVsd2VyZmFsbGlAbWVkY2hvLmNvbeKAnS4=?=
9From: "cPanel on medcho.com" <cpanel@medcho.com>
�+From: Souad <S-elemami@medcho.com>
	MMessage-ID: <763609f9-99df-49ae-96e6-7d5040e07ac2@email.android.com>
2Subject: =?UTF-8?B?2YPZitmBINit2KfZhNmD?=
�4>From: Moha Elshamy <mohaelshamy5@yahoo.com>
	FAMessage-ID: <2039966191.1268377.1687260309809@mail.yahoo.com>
;BSubject: Apply for opportunity from Egypt to Libya
�$From: no-reply@e.resmed.com
	k&Message-ID: <010101895a03253c-d9e07dd2-a84c-4cec-86b6-9b095e9ec3d7-000000@us-west-2.amazonses.com>
;"Subject: ResMed Account Registration Confirmation.
�,From: ResMed <webmaster@resmed.com>
	JMessage-Id: <20230715150149.B9E451914@fpfh-85f7.accessdomain.com>
&Subject: AirView Registration
CFrom: ResMed Customer Care <reply-customercare@resmed.com>
	p"Message-ID: <iY92P000000000000000000000000000000000000000000000RXUF3600RVvZ_MEqS2KQz3qjoadYcg@sfdc.net>
<#Subject: Web2Case AirView Network Registration Form
TA&From: "AirView Support (EU)" <support.airview@resmed.eu>
	p(Message-ID: <vOxjM000000000000000000000000000000000000000000000RYCC5H00aZAl83vNRS2rcF5bQkZ7Vw@sfdc.net>
-Subject: RE: AirView Registration (Ref: Case #05905415)    [
 ref:_00DD0lISy._5006NhhunP,_00D408oAA._5008Z2Dnwsi:ref ]
�*#From: noreply-identity@ersnet.org
	`!Message-Id: <5399ffc3.AUkAACLAzVgAAAAAAAAAAR8omNQAAAAAAA0AAAAAAAMLyABk59db@mailjet.com>
3%Subject: Confirm your ERS Account Creation
�0=From: ers2023registration@kit-group.org
	@@Message-ID: <14533428.23543.1693379177246@5e0a86cbd1cc>
XASubject: ERS 2023: Your registration is incomplete (Participant Number:
 16909)
�0=From: ers2023registration@kit-group.org
	B@Message-ID: <1526885625.61079.1693414079542@5e0a86cbd1cc>
XASubject: ERS 2023: Your registration is incomplete (Participant Number:
 16909)
DP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230904161516.c603ab7907.1f1afba7@mail81.atl111.rsgsv.net>
\'Subject: =?utf-8?Q?ERS=20Congress=202023=3A=20Industry=20partners=27=20activities?=
�0=From: ers2023registration@kit-group.org
	B@Message-ID: <1586123945.97767.1694018454521@5e0a86cbd1cc>
HASubject: ERS 2023: Payment Reminder (Participant Number: 16909)
�0=From: ers2023registration@kit-group.org
	A@Message-ID: <65866321.139091.1694071370143@5e0a86cbd1cc>
_ASubject: ERS 2023: Your invoice/registration confirmation (Participant
 Number: 16909)
�0=From: ers2023registration@kit-group.org
	B@Message-ID: <468815807.139095.1694071401037@5e0a86cbd1cc>
WASubject: ERS 2023: Access to pre-congress content (Participant number:
 16909)
,P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230907162026.013645cc3e.c3db7b2c@mail107.sea91.rsgsv.net>
D'Subject: =?utf-8?Q?ERS=20Newsletter=20=2D=207=20September?=
DP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	w,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230908171418.013108e88b.6b3338d1@mail205.atl271.mcdlv.net>
Y'Subject: =?utf-8?Q?The=20ERS=20International=20Congress=20starts=20tomorrow=21?=
DP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230909093024.e4d976adfc.3c86d67b@mail182.suw16.rsgsv.net>
\'Subject: =?utf-8?Q?ERS=20Congress=202023=3A=20Industry=20partners=27=20activities?=
�;-From: ResearchGate <no-reply@researchgatemail.net>
	L*Message-ID: <bfaab61d287f9b2ea06d00dc74a63fde@www.researchgate.net>
>,Subject: Zakaria, please confirm your account request
�;,From: ResearchGate <no-reply@researchgatemail.net>
	N)Message-ID: <74d60ed18c80d67a2053074ab7d357c9@internal-www.rgapi.net>
J+Subject: Zakaria, please help us verify that you are a researcher
@P(From: =?utf-8?Q?European=20Respiratory=20Society?= <noreply@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230914092944.29da10a6e1.389c97ea@mail56.suw111.mcdlv.net>
X'Subject: =?utf-8?Q?Thank=20you=20to=20all=20ERS=20Congress=202023=20attendees?=
HP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	t,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230914161948.b40b2c76fe.aedb5a2a@mail90.sea31.mcsv.net>
c'Subject: =?utf-8?Q?Check=20out=20the=20latest=20ERS=20Respiratory=20Channel=20highlights?=
?4From: Andrew Vozniuk <andrew.vozniuk@trtlogistics.com>
	Y6Message-ID: <CABtQii_OPOuhitUXZTuZHw-kUGqp0vWt5gdKU5jq+UNt0X-FAA@mail.gmail.com>
E7Subject: TRT International / Shipping cars from USA to Libya
?6From: Andrew Vozniuk <andrew.vozniuk@trtlogistics.com>
	Y8Message-ID: <CABtQii-wfqBDiFBUG1hOsYXkFvgJ+0UCHv4nBXP_bZofnsx3OA@mail.gmail.com>
I9Subject: Re: TRT International / Shipping cars from USA to Libya
LP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230918153421.ee9848c338.0b751247@mail78.atl301.rsgsv.net>
d'Subject: =?utf-8?Q?ERS=20Vision=20Live=3A=20Is=20TB=20elimination=20still=20achievable=3F?=
hP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	u,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230919163433.722e1a51ec.9562a90e@mail22.suw131.mcsv.net>
}'Subject: =?utf-8?Q?Lung=20Science=20Conference=202024=3A=20Registration=20and=20abstract=20submission=20open=20now?=
,P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	t,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230921165027.57015612cb.c5083335@mail48.sea31.mcsv.net>
E'Subject: =?utf-8?Q?ERS=20Newsletter=20=2D=2021=20September?=
(P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	t,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230926150007.a37d3414df.740e4774@mail48.sea31.mcsv.net>
B'Subject: =?utf-8?Q?Relive=20the=20ERS=20Congress=202023?=
LP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20230928161945.7482c9054c.947616b5@mail212.sea22.mcdlv.net>
c'Subject: =?utf-8?Q?Check=20out=20the=20latest=20ERS=20Respiratory=20Channel=20highlights?=
 P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	w,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231003160747.b73955d164.706b77f1@mail219.atl271.mcdlv.net>
7'Subject: =?utf-8?Q?Upcoming=20ERS=20webinars?=
,P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231005162056.8d13659c64.0b4bd3c5@mail36.atl261.mcdlv.net>
B'Subject: =?utf-8?Q?ERS=20Newsletter=20=2D=205=20October?=
pP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	t,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231010162030.b900563eb9.192a7ec6@mail19.atl91.mcsv.net>
�'Subject: =?utf-8?Q?ERS=20Vision=20Live=3A=20Climate=20Change=3A=20What=20clinicians=20need=20to=20know=20for=20their=20patients?=
HP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	t,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231012162132.6f8d9a1293.418a9a52@mail55.sea31.mcsv.net>
c'Subject: =?utf-8?Q?Check=20out=20the=20latest=20ERS=20Respiratory=20Channel=20highlights?=
`P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231017162129.27e6665ba2.8f5022d9@mail195.atl291.mcsv.net>
w'Subject: =?utf-8?Q?ERS=20Lung=20Science=20Conference=202024=3A=20two=20weeks=20to=20submit=20your=20abstract?=
,P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231019163714.5557f8e48c.e8534fee@mail137.atl81.rsgsv.net>
C'Subject: =?utf-8?Q?ERS=20Newsletter=20=2D=2019=20October?=
LP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231026162453.4f256bd2c7.35a27294@mail61.suw151.rsgsv.net>
c'Subject: =?utf-8?Q?Check=20out=20the=20latest=20ERS=20Respiratory=20Channel=20highlights?=
 P(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	u,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231030171229.d032c44bd0.357d7de4@mail55.sea21.rsgsv.net>
7'Subject: =?utf-8?Q?Upcoming=20ERS=20webinars?=
lP(From: =?utf-8?Q?European=20Respiratory=20Society?= <NOREPLY@ersnet.org>
	v,Message-ID: <07b6a7283a1da5b8e4d63ae64.d0adab75f5.20231113173122.1c2009ea59.9f934739@mail213.atl81.rsgsv.net>
�'Subject: =?utf-8?Q?ERS=20Vision=20Live=3A=20=20Is=20there=20a=20rationale=20for=20an=20early=20lung=20health=20check=3F?=
 (&From: ResMed <temp@e.resmed.eu>
	x*Message-Id: <5KBP.XX4G.DB548A2F46EC6F495N574T8C0D7EAF323B61A9.45f79d12-2565-4a56-a297-a7ad3bde40da@e.resmed.eu>
_(Subject: Missed our ERS NIV workshop Get expert clinical insights on the topic
 today!
�X8From: =?UTF-8?Q?Andre=C3=ADna_Mart=C3=ADnez_Santiso?= <amsantiso@inmunotek.com>
	Y:Message-ID: <CA+Q0Cw=W_JgFY7VH5UhhS36AscA7DtkuXPSaMFjnowCbEwoxog@mail.gmail.com>
';Subject: Inmunotek information
X;From: =?UTF-8?Q?Andre=C3=ADna_Mart=C3=ADnez_Santiso?= <amsantiso@inmunotek.com>
	Y=Message-ID: <CA+Q0CwnDZW5_anz4Z6rVruqAFzy=jon1DW7t_suJVmxZCBH4Jw@mail.gmail.com>
+>Subject: Re: Inmunotek information
:5From: Marina Malchenko <marinam@trtlogistics.com>
	Y7Message-ID: <CACfXBF5PFXe_iXFnTiToEjsiS6d34Mi61a0biRuo-XJk8u30sA@mail.gmail.com>
O8Subject: TRT International / Shipping cars from USA to Libya, El Khoms
:7From: Marina Malchenko <marinam@trtlogistics.com>
	Y9Message-ID: <CACfXBF7iFtVAD6r8HNcE6WLdyooEMzOFRX5U_P65=kq-vvmZHg@mail.gmail.com>
S:Subject: Re: TRT International / Shipping cars from USA to Libya, El Khoms
:8From: Marina Malchenko <marinam@trtlogistics.com>
	Y:Message-ID: <CACfXBF4j23K0gYsAT9ErnNUz4kHpjYvsXx-aEadPOYkORwM4kg@mail.gmail.com>
S;Subject: Re: TRT International / Shipping cars from USA to Libya, El Khoms
X<From: =?UTF-8?Q?Andre=C3=ADna_Mart=C3=ADnez_Santiso?= <amsantiso@inmunotek.com>
	Y>Message-ID: <CA+Q0Cwm7fWuR_OHU9_yy=E9QVoTZLgo5__q_w3LXA3_C_UbRkg@mail.gmail.com>
+?Subject: Re: Inmunotek information
�X?From: =?utf-8?Q?Andre=C3=ADna_Mart=C3=ADnez_Santiso?= <amsantiso@inmunotek.com>
	ICMessage-Id: <A36CB059-58A2-4543-91C7-EABA0BF4884B@inmunotek.com>
+ASubject: Re: Inmunotek information
0: From: TRT Express  <trtexpress@usatrt.ccsend.com>
	]Message-ID: <1141649662983.1139191935534.1394475486.0.321503JL.2002@synd.ccsend.com>
q#Subject:  Reliable Air Shipping for Time-Sensitive Cargo - Trust TRT Express
 with 30 Years of Expertise
8: From: TRT Express  <trtexpress@usatrt.ccsend.com>
	]Message-ID: <1141649722379.1139191935534.1394475486.0.320902JL.3010@synd.ccsend.com>
{#Subject: Reminder:  Reliable Air Shipping for Time-Sensitive Cargo - Trust
 TRT Express with 30 Years of Expertise
�78From: zakaria salem <zakariasalem44@gmail.com>
	Y:Message-ID: <CAHgomx5OxmyBwx_UVesHZm9uKZDk_L69y6oKBcHttE83iCEx1A@mail.gmail.com>
";Subject: inmunotek inqury
,8 From: TRT International <trt@usatrt.ccsend.com>
	]Message-ID: <1141726155724.1139191935534.1394475486.0.231322JL.2002@synd.ccsend.com>
t#Subject: =?utf-8?Q?Happy_Independence_Day_fro?=
 =?utf-8?Q?m_TRT_International!_=F0=9F=87=BA=F0=9F=87=B8_?=
: From: TRT Express  <trtexpress@usatrt.ccsend.com>
	]Message-ID: <1141726509674.1139191935534.1394475486.0.161650JL.2002@synd.ccsend.com>
W#Subject: Wishing you a joyous and safe July 4th from everyone at TRT
 Express!
;&From: Clinical Respiratory News <news@e.resmed.eu>
	y)Message-Id: <6LZQ.12FPZ.E002DA926E79ED085GGL755120961075CAE624.ce42f4c0-258f-4dfc-8f75-772d1bd604bf@e.resmed.eu>
D(Subject: ASV guidelines and evidence: what do they tell us?
 8 From: TRT International <trt@usatrt.ccsend.com>
	]Message-ID: <1141889906405.1139191935534.1394475486.0.231453JL.2002@synd.ccsend.com>
e#Subject: TRT International is going bigger and better than ever at Breakbulk
 Americas 2024!
(8 From: TRT International <trt@usatrt.ccsend.com>
	]Message-ID: <1141890006310.1139191935534.1394475486.0.230831JL.3010@synd.ccsend.com>
o#Subject: Reminder: TRT International is going bigger and better than ever at
 Breakbulk Americas 2024!
@;&From: Clinical Respiratory News <news@e.resmed.eu>
	y*Message-Id: <6LZQ.12ORI.E002DA926E79ED085GGL755120961075CAE624.bb2b3ccc-84c1-4aa1-bf3e-77e1b49f23d3@e.resmed.eu>
e(Subject: OnAir podcast: Breaking the barriers to diagnosis and treatment for
 women with OSA
4;&From: Clinical Respiratory News <news@e.resmed.eu>
	y*Message-Id: <6LZQ.1304L.E002DA926E79ED085GGL755120961075CAE624.2bcb2c4a-b833-4f8b-bdca-73d2069ff441@e.resmed.eu>
\(Subject: Listen to our latest podcast and get insights from ten must-read
 articles
5*From: Rasheed S.M <rasheedsm@biomedyard.com>
	e1Message-ID:
 <DX2P273MB0092D5931DCABE5EF3B59A68C17E2@DX2P273MB0092.AREP273.PROD.OUTLOOK.COM>
R-Subject: Fw: BIOMEDYARD LLC partnership with Al-Ekhtiar Al-Tebbi in Libya
5*From: Rasheed S.M <rasheedsm@biomedyard.com>
	e1Message-ID:
 <DX2P273MB00922D23092F5845DE50BD9AC17E2@DX2P273MB0092.AREP273.PROD.OUTLOOK.COM>
R-Subject: Re: BIOMEDYARD LLC partnership with Al-Ekhtiar Al-Tebbi in Libya
5*From: Rasheed S.M <rasheedsm@biomedyard.com>
	e1Message-ID:
 <DX2P273MB00929BAD35B2F051E7ED4884C17E2@DX2P273MB0092.AREP273.PROD.OUTLOOK.COM>
R-Subject: Re: BIOMEDYARD LLC partnership with Al-Ekhtiar Al-Tebbi in Libya
<;'From: Clinical Respiratory News <news@e.resmed.eu>
	y+Message-Id: <6LZQ.13M5G.E002DA926E79ED085GGL755120961075CAE624.c2af976b-cfbd-44d7-b60b-9b2e90fb1669@e.resmed.eu>
c)Subject: OnAir podcast: Exploring =?utf-8?b?QUnigJlz?= role in sleep and
 breathing health
�V"From: "GUANGZHOU ELECTRON TECHNOLOGY CO., LIMITED" <service@mail.pinprox.com>
	`%Message-ID: <1729843225692_105266_21149_8397.sg-10_2_255_162-inbound0@mail.pinprox.com>
;&Subject: =?utf-8?q?HOPE_TO_ESTABLISH_COOPERATION?=
4!Date: Fri, 25 Oct 2024 16:00:25 +0800 (CST)

.#Reply-To: coco-ye <coco-ye@yison.com>

3$To: z-elwerfalli <z-elwerfalli@medcho.com>
�("text" "html" ("charset" "UTF-8") NIL NIL "7bit" 2428 10 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_225230044_1251889505.1729843225666") NIL NIL NIL0Pg8 From: TRT International <trt@usatrt.ccsend.com>
	]Message-ID: <1142048421691.1139191935534.1394475486.0.211203JL.2002@synd.ccsend.com>
w#Subject: =?utf-8?Q?Happy_New_Year_from_TRT_Internati?=
 =?utf-8?Q?onal_=E2=80=93_Thank_You_for_Your_Support!?=
4Date: Tue, 31 Dec 2024 12:04:02 -0500 (EST)

'!Reply-To: marketing@usatrt.com

$"To: z-elwerfalli@medcho.com
("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 1314 16 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 22881 376 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_692909725_172254722.1735664642603") NIL NIL NIL$tg����c�vg�vg�vg�vg�vg$tg�vg�vg�vg$tg�vg�vg$tg�vg����������������������������������������������������date.receivedimap.bodystructurehdr.BCChdr.CChdr.DATEhdr.FROMhdr.GMAIL-CLIENT-DRAFT-IDhdr.GMAIL-CLIENT-DRAFT-THREAD-IDhdr.IN-REPLY-TOhdr.MESSAGE-IDhdr.REFERENCEShdr.REPLY-TOhdr.SUBJECThdr.TO��׺g�׺g�׺g�׺g�׺g���g�׺g�׺g�׺g���g�׺g�׺g���g�׺g�J�g�J�g��������������������������������������������������������date.receivedimap.bodystructurehdr.BCChdr.CChdr.DATEhdr.FROMhdr.GMAIL-CLIENT-DRAFT-IDhdr.GMAIL-CLIENT-DRAFT-THREAD-IDhdr.IN-REPLY-TOhdr.MESSAGE-IDhdr.REFERENCEShdr.REPLY-TOhdr.SUBJECThdr.TOflagsmime.partsHD� �A.~5^�_H]UX"H�TW�WaYx4A8From: Misha Yaremchuk <Misha.Yaremchuk@trtlogistics.com>
	Y;Message-ID: <CALt5Zj+QQh3o502NkJUjQQaCvpdZJbOiuCky+Je_KZS9cqnhGA@mail.gmail.com>
5<Subject: Car for sale VIN: 5TDBK22CX8S010582
%?Bcc: Z-elwerfalli@medcho.com
.9Date: Fri, 10 Jan 2025 13:37:48 -0500


=To: misha@usatrt.com
 pA��F�"�#A�NP�(\)H1+-B	}	;H�VY��f@�=��,T@%M��[��@�����1�?@�
��6��@����i|x@�����@g �����@k����̪@�|��@)-@����W�(�(("text" "plain" ("charset" "UTF-8") NIL NIL "7bit" 2429 59 NIL NIL NIL NIL)("text" "html" ("charset" "UTF-8") NIL NIL "quoted-printable" 7923 102 NIL NIL NIL NIL) "alternative" ("boundary" "000000000000cbcae6062b5e6497") NIL NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168548225579.jpg") "<f_m5r3nx8l1>" NIL "base64" 202836 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168548225579.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168548140906.jpg") "<f_m5r3nx7o0>" NIL "base64" 171246 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168548140906.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168548679067.jpg") "<f_m5r3nxae3>" NIL "base64" 278496 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168548679067.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168548805119.jpg") "<f_m5r3nxbb4>" NIL "base64" 173024 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168548805119.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168548328341.jpg") "<f_m5r3nx9i2>" NIL "base64" 292988 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168548328341.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168549175211.jpg") "<f_m5r3nxc75>" NIL "base64" 266196 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168549175211.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168549437185.jpg") "<f_m5r3nxd26>" NIL "base64" 180470 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168549437185.jpg")) NIL NIL)("image" "jpeg" ("name" "5TDBK22CX8S010582-1734168549444904.jpg") "<f_m5r3nxdx7>" NIL "base64" 174796 NIL ("attachment" ("filename" "5TDBK22CX8S010582-1734168549444904.jpg")) NIL NIL)("image" "png" ("name" "image (2).png") "<f_m5r3nxes8>" NIL "base64" 77084 NIL ("attachment" ("filename" "image (2).png")) NIL NIL)("application" "pdf" ("name" "Report.pdf") "<f_m5r3nxfn9>" NIL "base64" 469206 NIL ("attachment" ("filename" "Report.pdf")) NIL NIL) "mixed" ("boundary" "000000000000cbcae8062b5e6499") NIL NIL NILi�g84� �A���fZhA�NP��H+-He*,@�(0Md�e�*T <A�R��^9ANP!+�+H�WZ��;H~VY�"#t@�@ '�k�l@g����#�Y@j���.�B�;'From: Clinical Respiratory News <news@e.resmed.eu>
	y*Message-Id: <6LZQ.159QA.E002DA926E79ED085GGL755120961075CAE624.6923d94d-c353-494d-a10e-2d9a1539370e@e.resmed.eu>
M)Subject: 2024 in review: a year of respiratory research and insights
.+Date: Thu, 30 Jan 2025 12:01:33 +0000

U5Reply-To: Clinical Respiratory News <re-6LZQ-159QA-5GGL75-C215X@e.resmed.eu>

$(To: z-elwerfalli@medcho.com
 �A��?�a�H�UX[�sH�+����@��)("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 5838 115 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") "<QWTPIGKU9PU4.T95N53QM9J982@turbodroid-ddff7658-9jtgw>" NIL "quoted-printable" 59200 931 NIL NIL NIL NIL) "alternative" ("boundary" "=-k85Iwllfi3vvXAzg0SnL5Q==") NIL NIL NIL$j�g�('From: ResMed <news@e.resmed.eu>
	y*Message-Id: <6LZQ.1587G.E002DA926E79ED085GGL755120961075CAE624.51450810-2d95-42e0-b395-634568cd8483@e.resmed.eu>
M)Subject: Our next-generation AirSense 11 is now available in the UK!
.+Date: Mon, 03 Feb 2025 11:02:23 +0000

B5Reply-To: ResMed <re-6LZQ-1587G-5GGL75-C2161@e.resmed.eu>

$(To: z-elwerfalli@medcho.com
 �A[��'HxUX��-H�����d(("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 2273 45 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") "<CNF7AT72BPU4.2Z8D0SOYI4V9@turbodroid-ddff7658-9sh2x>" NIL "quoted-printable" 70644 1124 NIL NIL NIL NIL) "alternative" ("boundary" "=-fDPhjZFyT9AirdKEWfs5lA==") NIL NIL NILG��gP?� �AH*�*$�)H�*\_��H�A[^$�L�(H�`c0�0��:"From: Maxevis ---Smile <service@mail.pinleds.com>
	_%Message-ID: <1740148433626_105266_24976_9297.sg-10_1_253_30-inbound0@mail.pinleds.com>
0&Subject: =?utf-8?q?Ai_Mouse_promoiton?=
4!Date: Fri, 21 Feb 2025 22:33:53 +0800 (CST)

2#Reply-To: sales001 <sales001@maxevis.com>

3$To: z-elwerfalli <z-elwerfalli@medcho.com>
 XA���	H�JM;P�("text" "html" ("charset" "UTF-8") NIL NIL "7bit" 5968 21 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_16015882_1866365261.1740148433603") NIL NIL NIL���g
https://t.me/AnonymousX5 - 2025